PCMC
NVCR icon

Planning Capital Management Corporation’s NovoCure NVCR Stock Holding History

Planning Capital Management Corporation’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$79 Hold
5
– – ﹤0.01% 726
2024
Q2 		$86 Buy
+5
New +$88 ﹤0.01% 670

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
NA
Nordwand Advisors Radnor, Pennsylvania $572M AUM 23.09% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Planning Capital Management Corporation's NVCR Position: Q3 2024 in Review

Planning Capital Management Corporation held its NovoCure (NVCR) position steady in Q3 2024 at 5 shares worth $79. The position accounts for ﹤0.01% of the portfolio, ranked #726.

Planning Capital Management Corporation first reported a position in NVCR in Q2 2024 and has held it in 2 quarters since. The position peaked at $86 in Q2 2024. 225 funds tracked by Wall St. Rank hold NVCR as of Q3 2024.

  • Planning Capital Management Corporation held 5 shares of NovoCure worth $79 as of Q3 2024.
  • Planning Capital Management Corporation left its NovoCure share count unchanged in Q3 2024.
  • NovoCure made up ﹤0.01% of Planning Capital Management Corporation's portfolio in Q3 2024, its #726 holding.
  • Planning Capital Management Corporation first reported a position in NovoCure in Q2 2024 and has held it in 2 quarters since.
  • Planning Capital Management Corporation's NovoCure position peaked at $86 in Q2 2024.
  • 225 funds tracked by Wall St. Rank held NovoCure as of Q3 2024.

Based on Planning Capital Management Corporation's 13F filing for Q3 2024, filed 6 Nov 2024.